Lynda Charters

DRSS results remained stable or improved with OKT-TKI, and the drug was well-tolerated in the study.

Scleral lens choice led to marked improvements of HOAs caused by radial keratotomy-induced scarring and corneal shape irregularities.

The longitudinal study found that visual function and BCVA decreased with an increasing incidence rate of moderate and severe visual impairment for patients with high myopia.

Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia progressed at a rate of −0.17 D annually after switching to single-vision lenses.

The investigators used National Health and Nutrition Examination Survey data in a cross-sectional study to determine the association between Dietary Inflammatory Index and non-refractive visual impairment from diseases other than cataract and age-related macular degeneration.

Nocturnal hypoxia could be a new additional modifiable risk factor for nAMD.

Educational material available include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, and a dedicated webpage.

The 98 patients included in the study were from a retina outpatient clinic and were using 0.3% ofloxacin eye drops as prophylaxis against infection.

The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.

After reviewing information collected on a patient database, the team suggested telephone prompts for patients with mental health concerns, text message reminders, and online educational tools to improve uptake to increase eye screening attendance.

Brolucizumab significantly improves anatomic parameters of patients with diabetic macular edema.

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used hair dyes.

While no infections or adverse events have been reported, fungal contamination can pose a serious risk of eye infections.

The authors searched websites including PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports with an association between RVO and heart attack risk.

Research was based on results of a double-blinded, randomized, clinical trial performed between November 2017 and December 2022 in the strabismus clinic of Farabi Eye Hospital.

The researchers identified 940 teprotumumab-associated adverse events that included 84 hearing-related adverse events. The first was reported to the FDA in April 2020.

Brush up your geographic atrophy knowledge with our 2024 content highlights.

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

Inside the role of blepharitis in ocular surface disease and effective management strategies.

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children.

Relapse and chronic uveitis can occur after infectious uveitis was treated successfully, study authors found.

The primary findings were that a higher BMI was protective against glaucoma progression and use of tobacco and alcohol were not significantly associated with retinal nerve fiber layer change.

The retrospective study investigated and analyzed the severity and frequency of ocular pain and factors affecting it among DED patients living in high altitudes above 2500 meters during the COVID-19 pandemic.

The incidence was comparable to that of daily wear soft contact lenses.

Additional research is needed to establish best diagnostic and management strategies for increasingly common condition.

A retrospective cohort study was designed to provide further information on the association between BP parameters and VF progression over time.

AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions.

Increased choroidal thickness also was seen in children treated with 1% atropine for 1 week or 0.01% atropine for less than 8 weeks.